Suppr超能文献

小鼠去甲肾上腺素转运体的分子克隆与功能表达

Molecular cloning and functional expression of the murine noradrenaline transporter.

作者信息

Muck Andrea, Gilsbach Ralf, Löbbe-Werner Sandra, Brüss Michael, Bönisch Heinz

机构信息

Institute of Pharmacology and Toxicology, University of Bonn, Reuterstr. 2 b, 53113 Bonn, Germany.

出版信息

Naunyn Schmiedebergs Arch Pharmacol. 2007 Oct;376(1-2):65-71. doi: 10.1007/s00210-007-0181-7. Epub 2007 Sep 19.

Abstract

The cDNA of the murine noradrenaline transporter (mNAT) was cloned from the RNA of the placenta of a C57BL/6 mouse. The cloned mNAT differs from a previously published sequence in two amino acids within the C-terminal region. A cDNA obtained from an inbred mouse strain showed a further amino acid exchange (Ile(505)Val) within the fifth intracellular loop. The pharmacological properties of both, the wild-type mNAT and the variant (mNAT-I(505)V), were studied in human embryonic kidney HEK293 cells transfected with the corresponding cDNA. The kinetic constants for transport (K (m), V (max)) of [(3)H]noradrenaline ([(3)H]-NA) and binding (K (D), B (max)) of the selective NAT inhibitor [(3)H]nisoxetine were not different between the two isoforms; the mean kinetic constants amounted to about 4 microM and 120pmol/mg protein for K (m) and V (max) and 6nM and 18pmol/mg protein for K (D) and B (max), respectively. [(3)H]-NA transport by both isoforms showed the typical properties of an NAT because it was dependent on sodium and chloride and inhibited with almost identical K (i) values by various NAT substrates and inhibitors. The only significant pharmacological difference identified between the two mNAT isoforms was an about threefold higher affinity for cocaine of the very rare mNAT-I(505)V variant.

摘要

从小鼠(C57BL/6)胎盘RNA中克隆出小鼠去甲肾上腺素转运体(mNAT)的cDNA。克隆得到的mNAT在C末端区域的两个氨基酸上与之前发表的序列不同。从一个近交系小鼠品系获得的cDNA在第五个细胞内环内还显示出另一个氨基酸交换(Ile(505)Val)。分别用野生型mNAT和变异体(mNAT-I(505)V)的cDNA转染人胚肾HEK293细胞,研究了它们的药理学特性。两种异构体对[³H]去甲肾上腺素([³H]-NA)的转运动力学常数(Km、Vmax)以及对选择性去甲肾上腺素转运体抑制剂[³H]尼索西汀的结合动力学常数(KD、Bmax)并无差异;两种异构体的平均动力学常数分别为:Km约4μM、Vmax约120pmol/mg蛋白,KD约6nM、Bmax约18pmol/mg蛋白。两种异构体对[³H]-NA的转运均表现出去甲肾上腺素转运体的典型特性,因为其依赖于钠和氯,并且被各种去甲肾上腺素转运体底物和抑制剂以几乎相同的抑制常数(Ki)所抑制。在两种mNAT异构体之间发现的唯一显著药理学差异是非常罕见的mNAT-I(505)V变异体对可卡因的亲和力高约三倍。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验